Cargando…
Primary breast cancer in a patient with Wilson disease: A case report
RATIONALE: Wilson disease (WD) is an autosomal recessive hereditary disease in which the patient usually has a reduced risk of developing cancer. In particular, with the exception of hepatocellular carcinoma and cholangiocarcinoma, the incidence of cancer is significantly lower in WD patients compar...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531091/ https://www.ncbi.nlm.nih.gov/pubmed/31083157 http://dx.doi.org/10.1097/MD.0000000000015266 |
_version_ | 1783420752972742656 |
---|---|
author | Li, Dong Wang, Jun Gao, Jinnan |
author_facet | Li, Dong Wang, Jun Gao, Jinnan |
author_sort | Li, Dong |
collection | PubMed |
description | RATIONALE: Wilson disease (WD) is an autosomal recessive hereditary disease in which the patient usually has a reduced risk of developing cancer. In particular, with the exception of hepatocellular carcinoma and cholangiocarcinoma, the incidence of cancer is significantly lower in WD patients compared with the general population. This case study presents a rare case of WD complicated with primary breast cancer. PATIENT CONCERNS: A 40-year-old woman who was diagnosed with WD at 25 years of age found a lump in her left breast. She has a family history of cancer. DIAGNOSES: Ultrasound and mammography results were highly suggestive of a malignant lesion. After core needle biopsy, it was confirmed that she had invasive breast cancer. INTERVENTIONS: A modified radical mastectomy was performed for the left breast. As the tumor was defined as a stage IIa triple negative breast cancer, the patient would have been recommended epirubicin/cyclophosphamide + docetaxel for 8 cycles if WD was not a comorbidity. As the patient had cirrhosis and abnormal liver function, she was given paclitaxel weekly for 6 cycles instead. OUTCOMES: The patient showed good tolerance, and has not had a recurrence in 2 years. LESSONS: We reviewed the literature for studies of patients with WD complicated with cancers, and to our knowledge, this is the first report on WD complicated with breast cancer. The patient received chemotherapy even with liver dysfunction, which suggests that patients with WD can be safely treated with paclitaxel chemotherapy under close surveillance. |
format | Online Article Text |
id | pubmed-6531091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-65310912019-06-25 Primary breast cancer in a patient with Wilson disease: A case report Li, Dong Wang, Jun Gao, Jinnan Medicine (Baltimore) Research Article RATIONALE: Wilson disease (WD) is an autosomal recessive hereditary disease in which the patient usually has a reduced risk of developing cancer. In particular, with the exception of hepatocellular carcinoma and cholangiocarcinoma, the incidence of cancer is significantly lower in WD patients compared with the general population. This case study presents a rare case of WD complicated with primary breast cancer. PATIENT CONCERNS: A 40-year-old woman who was diagnosed with WD at 25 years of age found a lump in her left breast. She has a family history of cancer. DIAGNOSES: Ultrasound and mammography results were highly suggestive of a malignant lesion. After core needle biopsy, it was confirmed that she had invasive breast cancer. INTERVENTIONS: A modified radical mastectomy was performed for the left breast. As the tumor was defined as a stage IIa triple negative breast cancer, the patient would have been recommended epirubicin/cyclophosphamide + docetaxel for 8 cycles if WD was not a comorbidity. As the patient had cirrhosis and abnormal liver function, she was given paclitaxel weekly for 6 cycles instead. OUTCOMES: The patient showed good tolerance, and has not had a recurrence in 2 years. LESSONS: We reviewed the literature for studies of patients with WD complicated with cancers, and to our knowledge, this is the first report on WD complicated with breast cancer. The patient received chemotherapy even with liver dysfunction, which suggests that patients with WD can be safely treated with paclitaxel chemotherapy under close surveillance. Wolters Kluwer Health 2019-05-13 /pmc/articles/PMC6531091/ /pubmed/31083157 http://dx.doi.org/10.1097/MD.0000000000015266 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | Research Article Li, Dong Wang, Jun Gao, Jinnan Primary breast cancer in a patient with Wilson disease: A case report |
title | Primary breast cancer in a patient with Wilson disease: A case report |
title_full | Primary breast cancer in a patient with Wilson disease: A case report |
title_fullStr | Primary breast cancer in a patient with Wilson disease: A case report |
title_full_unstemmed | Primary breast cancer in a patient with Wilson disease: A case report |
title_short | Primary breast cancer in a patient with Wilson disease: A case report |
title_sort | primary breast cancer in a patient with wilson disease: a case report |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531091/ https://www.ncbi.nlm.nih.gov/pubmed/31083157 http://dx.doi.org/10.1097/MD.0000000000015266 |
work_keys_str_mv | AT lidong primarybreastcancerinapatientwithwilsondiseaseacasereport AT wangjun primarybreastcancerinapatientwithwilsondiseaseacasereport AT gaojinnan primarybreastcancerinapatientwithwilsondiseaseacasereport |